Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood- CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis

FASEB Journal

Volumn 14, Issue 5, 2000, Pages 691-698

  Hooper, D C ^a   Scott, G S ^a   Zborek, A ^a,b   Mikheeva, T ^a   Kean, R B ^a   Koprowski, H ^a   Spitsin, S V ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Autoimmunity; Blood brain barrier; Demyelinating diseases; Encephalomyelitis; Multiple Sclerosis; Uric acid

Indexed keywords

URIC ACID;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; DISEASE ASSOCIATION; HUMAN; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NITRATION; PERMEABILITY; PRIORITY JOURNAL; TISSUE INJURY;

ANIMALIA;

EID: 0034038044     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.5.691     Document Type: Article

References (49)

1. Bö, L., Dawson, T. M., Wesselingh, S., Mörk, S., Choi, S., Kong, P. A., Hanley, D., and Trapp, B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786
2. Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawdros, R., and Koprowski, H. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92, 12041-12045
3. Okuda, Y., Sakoda, S., Fujimura, H., and Yanagihara, T. (1995) Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-112
4. Hooper, D. C., Ohnishi, S. T., Kean, R., Numagami, Y., Dietzschold, B., and Koprowski, H. (1995) Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92, 5312-5316
5. Cross, A. H., Keeling, R. M., Goorha, S., San, M., Rodi, C., Wyatt, P. S., Manning, P. T., and Misko, T. P. (1996) Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J. Neuroimmunol. 71, 145-153
6. Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., and Dietzschold, B. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027
7. Schuman, E. M., and Madison, D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506
8. Moncada, S., and Higgs, A. (1993) The L-arginine nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012
9. Bauer, H., Jung, T., Tsikas, D., Stichtenoth, D. O., Frohlich, J. C., and Neumann, C. (1997) Nitric oxide inhibits the secretion of T-helper 1 and T-helper 2-associated cytokines in activated human T cells. Immunology 90, 205-211
10. Alberati-Giani, D., Malherbe, P., Ricciardi-Castagnoli, P., Köhler, C., Denis-Donini, S., and Cesura, A. M. (1997) Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-γ-activated macrophages and microglial cells. J. Immunol. 159, 419L-426L
11. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite induced lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487
12. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250
13. -. Free Rad. Biol. Med. 21, 855-869
14. Beckman, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., and White C. R. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. 375, 81-88
15. Hooper, D. C., Bagasra, O., Marini, J. C., Zborek, A., Ohnishi, S. T., Kean, R., Champion, J. M., Sarker, A. B., Bobroski, L., Farber, J. L., Akaike, T., Maeda, H., and Koprowski, H. (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl Acad. Sci. USA 94, 2528-2533
16. Cross, A. H., Maning, P. T., Keeling, R. M., Schmidt, R. E., and Misko, T. P. (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88, 45-56
17. van der Veen, R. C., Hinton, D. R., Incardonna, F., and Hofman, F. M. (1997) Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77, 1-7
18. Cross, A. H., Maning, P. T., Stern, M. K., and Misko, T. P. (1997) Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80, 121-130
19. Shergill, J. K., Cammack, R., Cooper, J. M., Mann, V. M., and Schapira, A. H. (1996) Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease. Biochem. Biophys. Res. Commun. 228, 298-305
20. Wallace, M. N., Geddes, J. G., Farquhar, D. A., and Masson, M. R. (1997) Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp. Neurol. 144, 266-272
21. Chou, S. M., Wang, H. S., and Tanaguchi, A. (1996) Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J. Neurol. Sci. 139 (Suppl.), 16-26
22. 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Rad. Res. 25, 275-283
23. Hooper, D. C., Spitsin, S., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudrhy, I., and Koprowski, H. (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 95, 675-680
24. Usuda, N., Reddy, M. K., Hashimoto, T., Rao, M. S., and Reddy, J. K. (1988) Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes. Lab. Invest. 58, 100-111
25. Lehniger, A. L. (1970) Biochemistry, 833 pp., Worth Publishers Inc., New York
26. Varela-Eschavarria, A., Montes de Oca-Luna, R., and Barrera-Saldana H. A. (1988) Uricase protein sequences: conserved during hominid evolution but absent in humans. FASEB J. 2, 3092-3096
27. Wu, X. W., Muzny, D. M., Lee, C. C., and Catskey, C. T. (1992) Two independent mutational events in the loss of urate oxidase during hominid evolution. J. Mol. Evol. 34, 78-84
28. Yeldandi, A. V., Yeldandi, V., Kumar, S., Murthy, C. V., Wang, X. D., Alvares, K., Rao, M. S., and Reddy, J. K. (1991) Molecular evolution of the urate oxidase-encoding gene in hominid primates: nonsense mutations. Gene 109, 281-284
29. Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J., Smith, C., and Beckman, J. (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298, 431-437
30. Elias, J. M., Margiotta, M., and Gaboric, D. (1989) Sensitivity and detection efficiency of the peroxidase antiperoxidase PAP. avidin-biotin peroxidase complex ABC., and peroxidase-labeled avidin-biotin LAB. methods. Am. J. Clin. Pathol. 92, 62-67
31. Mangoff, S. C., and Milner, J. A. (1978) Oxonate-induced hyperuricemia and orotic aciduris in mice. Proc. Soc. Exp. Biol. Med. 157, 110-115
32. Kock, R., Delvoux, B., and Greiling H. (1992) A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid, and allantoin in serum. Eur. J. Clin. Chem. Clin. Biochem. 31, 303-310
33. Wolman, M., Klatzo, I., Chui, E., Wilmes, F., Nishimoto, K., Fujiwara, K., and Spatz, M. (1981) Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. 54, 55-61
34. Koenig, H., Goldstone, A. D., and Lu, C. Y. (1989) Blood-brain barrier breakdown in cold-injured brain is linked to a biphasic stimulation of ornithine decarboxylase activity and polyamine synthesis: both are coordinately inhibited by verapamil, dexamethasone, and aspirin. J. Neurochem. 52, 101-109
35. Trout, J. J., Koenig, H., Goldstone, A. D., and Lu, C. Y. (1986) Blood-brain barrier breakdown by cold injury. Polyamine signals mediate acute stimulation of endocytosis, vesicular transport, and microvillus formation in rat cerebral capillaries. Lab. Invest. 55, 622-631
36. Waldner, H., Sobel, R. A., Howard, E., and Kuchroo, V. K. (1997) Fas- and fasI.-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159, 3100-3103
37. Pender, M. P., Nguyen, K. B., McCombe, P. A., and Kerr, J. F. R. (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104, 81-87
38. Claudio, L., Raine, C. S., and Brosnan, C. F. (1995) Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 90, 228-238
39. Funder, J., and Wieth, J. O. (1967) Changes in cerebrospinal fluid composition following hemodialysis. Lab. Invest. 19, 310-312
40. Honegger, C. G., Krenger, W., and Langemann, H. (1986) Increased concentrations of uric acid in the spinal cord of rats with chronic relapsing experimental allergic encephalomyelitis. Neurosci. Lett. 69, 109-114
41. Guy, J., McGorray, S., Qi, X., Fitzsimmons, J., Mancuso, A., and Rao, N. (1994) Conjugated deferoxamine reduces blood-brain barrier disruption in experimental optic neuritis. Opthalmic Res. 26, 310-323
42. Greenacre, S., Ridger, V., Wilsoncroft, P., and Brain, S. (1997) Peroxynitrite: a mediator of increased microvascular permeability? Clin. Exp. Pharmacol. Physiol. 24, 880-882
43. Merrill, J. E., and Murphy, S. (1997) Inflammatory events at the blood-brain barrier: regulation of adhesion molecules, cytokine and chemokines by reactive nitrogen and oxygen species. Brain Behav. Immunity 11, 245-263
44. Keilin, J. (1959) The biological significance of uric acid and guanine excretion. Biol. Rev. 34, 265-296
45. Seegmiller, J. E., Laster, L., and Howell, R. R. (1963) Biochemistry of uric acid and its relation to gout. N. Engl. J. Med. 268, 712-716
46. Campion, E. W., Glynn, R. J., and DeLabry, L. O. (1987) Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am. J. Med. 82, 421-426
47. Proctor, P. (1970) Similar functions of uric acid and ascorbate in man? Nature (London) 228, 868
48. Ames, B. N., Cathcart, R. Schwiers, E., and Hochstein, P. (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 78, 6858-6862
49. Church, W. H., and Ward, V. L. (1994) Uric acid is reduced in the substantia nigra in Parkinson's disease: effect of dopamine oxidation. Brain Res. Bull. 33, 419-425